David P. Ward

Addrenex Pharmaceuticals, Inc. manufactures pharmaceuticals and drugs. Its focus on adrenergic regulation is indicated in therapeutic categories such as hypertension, ADHD, migraine and post-menopausal symptoms. The company was founded by H. Joseph Horacek and Moise A. Khayrallah in June 2006 and is headquartered in Durham, NC.

Part of Procter & Gamble Co., SmithKline & French SpA is a pharmaceutical concern. SmithKline & French was acquired by Procter & Gamble Co. from Smithkline Beecham Plc on September 29, 1993.

Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK.

VTVX Holdings I LLC discovers, develops and commercializes human therapeutics to fill unmet medical needs. Its products include a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a range of human diseases, including central nervous system disorders, cardiovascular disorders, type I/II diabetes, obesity, metabolic diseases, inflammatory diseases, female sexual dysfunction, primary open angle glaucoma and cancer. The company was founded in 1998 by Dr. Adnan M. M. Mjalli and is headquartered in High Point, NC.

Aerial BioPharma LLC operates as a biopharmaceutical company. It focuses on developing biologics and small molecules for conditions that are affected by processes in the Central Nervous System. The company was founded by Moise A. Khayrallah, stephen E. Butts and Gary Bream in January 2011 and is headquartered in Morrisville, NC.

Neuronex, Inc. developed drugs to treat central nervous system diseases and disorders. The company was founded by Stephen Butts and Moise Khayrallah in 2010 and was headquartered in Morrisville, NC.